Functional correction of type VII collagen expression in dystrophic epidermolysis bullosa

Journal of Investigative Dermatology

Volumn 131, Issue 1, 2011, Pages 74-83

  Murauer, Eva M ^a   Gache, Yannick ^b,c   Gratz, Iris K ^a,d   Klausegger, Alfred ^a   Muss, Wolfgang ^a   Gruber, Christina ^a   Meneguzzi, Guerrino ^b,c   Hintner, Helmut ^a   Bauer, Johann W ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b INSERM   (France)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 7; COMPLEMENTARY DNA;

ARTICLE; BASEMENT MEMBRANE; CELL INVASION; CELL STRUCTURE; CONTROLLED STUDY; EPIDERMOLYSIS BULLOSA DYSTROPHICA; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TRANS SPLICING;

EID: 78650297492     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.249     Document Type: Article

References (47)

1. Baldeschi C, Gache Y, Rattenholl A et al. (2003) Genetic correction of canine dystrophic epidermolysis bullosa mediated by retroviral vectors. Hum Mol Genet 12:1897-905
2. Barrandon Y, Green H (1987) Three clonal types of keratinocyte with different capacities for multiplication. Proc Natl Acad Sci USA 84:2302-6
3. Baum C, Dullmann J, Li Z et al. (2003) Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 101:2099-114
4. Bruckner-Tuderman L, Nilssen O, Zimmermann DR et al. (1995) Immuno-histochemical and mutation analyses demonstrate that procollagen VII is processed to collagen VII through removal of the NC-2 domain. J Cell Biol 131:551-9
5. Burgeson RE (1993) Type VII collagen, anchoring fibrils, and epidermolysis bullosa. J Invest Dermatol 101:252-5
6. Chao H, Mansfield SG, Bartel RC et al. (2003) Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing. Nat Med 9:1015-9
7. Chen M, Kasahara N, Keene DR et al. (2002) Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa. Nat Genet 32:670-5
8. Chen M, O'Toole EA, Muellenhoff M et al. (2000) Development and characterization of a recombinant truncated type VII collagen "mini-gene". Implication for gene therapy of dystrophic epidermolysis bullosa. J Biol Chem 275:24429-35
9. Christiano AM, Greenspan DS, Lee S et al. (1994a) Cloning of human type VII collagen. Complete primary sequence of the alpha 1(VII) chain and identification of intragenic polymorphisms. J Biol Chem 269: 20256-62
10. Christiano AM, Hoffman GG, Chung-Honet LC et al. (1994b) Structural organization of the human type VII collagen gene (COL7A1), composed of more exons than any previously characterized gene. Genomics 21:169-79
11. Dallinger G, Puttaraju M, Mitchell LG et al. (2003) Development of spliceosome-mediated RNA trans-splicing (SMaRT (TM)) for the correction of inherited skin diseases. Exp Dermatol 12:37-46
12. Dang N, Murrell DF (2008) Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa. Exp Dermatol 17:553-68
13. Del Rio M, Larcher F, Serrano F et al. (2002) A preclinical model for the analysis of genetically modified human skin in vivo. Hum Gene Ther 13:959-68
14. Del Rio M, Gache Y, Jorcano JL et al. (2004) Current approaches and perspectives in human keratinocyte-based gene therapies. Gene Ther 11(Suppl 1):S57-63
15. Dingemans KP, Van Den Bergh Weerman MA (1990) Rapid contrasting of extracellular elements in thin sections. Ultrastruct Pathol 14:519-27
16. Fine JD, Eady RA, Bauer EA et al. (2008) The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 58:931-50
17. Fischer A, Cavazzana-Calvo M (2005) Integration of retroviruses: a fine balance between efficiency and danger. PloS Med 2:e10
18. Fritsch A, Loeckermann S, Kern JS et al. (2008) A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy. J Clin Invest 118:1669-79
19. Gache Y, Baldeschi C, Del Rio M et al. (2004) Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa. Hum Gene Ther 15:921-33
20. Goto M, Sawamura D, Nishie W et al. (2006) Targeted skipping of a single exon harboring a premature termination codon mutation: implications and potential for gene correction therapy for selective dystrophic epidermolysis bullosa patients. J Invest Dermatol 126:2614-20
21. Hacein-Bey-Abina S, von Kalle C, Schmidt M et al. (2003) A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348:255-6
22. Heinonen S, Mannikko M, Klement JF et al. (1999) Targeted inactivation of the type VII collagen gene (Col7a1) in mice results in severe blistering phenotype: a model for recessive dystrophic epidermolysis bullosa. J Cell Sci 112(Part 21):3641-8
23. Ito K, Sawamura D, Goto M et al. (2009) Keratinocyte-/fibroblast-targeted rescue of Col7a1-disrupted mice and generation of an exact dystrophic epidermolysis bullosa model using a human COL7A1 mutation. Am J Pathol 175:2508-17
24. Khavari PA, Rollman O, Vahlquist A (2002) Cutaneous gene transfer for skin and systemic diseases. J Intern Med 252:1-10
25. Larcher F, Dellambra E, Rico L et al. (2007) Long-term engraftment of single genetically modified human epidermal holoclones enables safety pre-assessment of cutaneous gene therapy. Mol Ther 15:1670-6
26. Mallipeddi R (2002) Epidermolysis bullosa and cancer. Clin Exp Dermatol 27:616-23
27. Mansfield SG, Kole J, Puttaraju M et al. (2000) Repair of CFTR mRNA by spliceosome-mediated RNA trans-splicing. Gene Ther 7:1885-95
28. Martins VL, Vyas JJ, Chen M et al. (2009) Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen. J Cell Sci 122:1788-99
29. Mavilio F, Pellegrini G, Ferrari S et al. (2006) Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med 12:1397-402
30. Meana A, Iglesias J, Del Rio M et al. (1998) Large surface of cultured human epithelium obtained on a dermal matrix based on live fibroblast-containing fibrin gels. Burns 24:621-30
31. Mecklenbeck S, Compton SH, Mejia JE et al. (2002) A microinjected COL7A1-PAC vector restores synthesis of intact procollagen VII in a dystrophic epidermolysis bullosa keratinocyte cell line. Hum Gene Ther 13:1655-62
32. Michiels F, van der Kammen RA, Janssen L et al. (2000) Expression of Rho GTPases using retroviral vectors. Methods Enzymol 325:295-302
33. Morgan RA, Anderson WF (1993) Human gene therapy. Annu Rev Biochem 62:191-217
34. Morris NP, Keene DR, Glanville RW et al. (1986) The tissue form of type VII collagen is an antiparallel dimer. J Biol Chem 261:5638-44
35. Nolan GP, Shatzman AR (1998) Expression vectors and delivery systems. Curr Opin Biotechnol 9:447-50
36. Ortiz-Urda S, Thyagarajan B, Keene DR et al. (2002) Stable nonviral genetic correction of inherited human skin disease. Nat Med 8:1166-70
37. Porteus MH, Connelly JP, Pruett SM (2006) A look to future directions in gene therapy research for monogenic diseases. PloS Genet 2:e133
38. Pulkkinen L, Uitto J (1999) Mutation analysis and molecular genetics of epidermolysis bullosa. Matrix Biol 18:29-42
39. Puttaraju M, Jamison SF, Mansfield SG et al. (1999) Spliceosome-mediated RNA trans-splicing as a tool for gene therapy. Nat Biotechnol 17:246-52
40. Rheinwald JG, Green H (1975) Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6:331-43
41. Schmidt M, Carbonaro DA, Speckmann C et al. (2003) Clonality analysis after retroviral-mediated gene transfer to CD34+ cells from the cord blood of ADA-deficient SCID neonates. Nat Med 9:463-8
42. Schwarzwaelder K, Howe SJ, Schmidt M et al. (2007) Gammaretrovirus- mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo. J Clin Invest 117:2241-9
43. Tahara M, Pergolizzi RG, Kobayashi H et al. (2004) Trans-splicing repair of CD40 ligand deficiency results in naturally regulated correction of a mouse model of hyper-IgM X-linked immunodeficiency. Nat Med 10:835-41
44. Tidman MJ, Eady RA (1985) Evaluation of anchoring fibrils and other components of the dermal-epidermal junction in dystrophic epidermo-lysis bullosa by a quantitative ultrastructural technique. J Invest Dermatol 84:374-7
45. Uitto J, Pulkkinen L (2001) Molecular genetics of heritable blistering disorders. Arch Dermatol 137:1458-61
46. Venable JH, Coggeshall R (1965) A simplified lead citrate stain for use in electron microscopy. J Cell Biol 25:407-8
47. 0 trans-splicing repair of the PLEC1 gene. J Invest Dermatol 128:568-74